General Information of Drug (ID: DMUQN83)

Drug Name
FL-386
Synonyms Benzene sulfonic acid 2-(trans-4-isobutylcyclohexyl)-2-oxoethyl ester
Indication
Disease Entry ICD 11 Status REF
Hyperlipidaemia 5C80 Discontinued in Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 338.5
Logarithm of the Partition Coefficient (xlogp) 4.6
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C18H26O4S
IUPAC Name
[2-[4-(2-methylpropyl)cyclohexyl]-2-oxoethyl] benzenesulfonate
Canonical SMILES
CC(C)CC1CCC(CC1)C(=O)COS(=O)(=O)C2=CC=CC=C2
InChI
InChI=1S/C18H26O4S/c1-14(2)12-15-8-10-16(11-9-15)18(19)13-22-23(20,21)17-6-4-3-5-7-17/h3-7,14-16H,8-13H2,1-2H3
InChIKey
RLVLLBHWAQWLKL-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
134847
CAS Number
84856-18-8
TTD ID
D05YLL

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dihydrothymine dehydrogenase (DPYD) TTZPS91 DPYD_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002285)
2 Effects of FL-386 on faecal lipid excretion in humans. J Int Med Res. 1993 Sep-Oct;21(5):225-33.